UniProtKB/Swiss-Prot P04792 : Variant p.Pro7Ser
Heat shock protein beta-1
Gene: HSPB1
Feedback ?
Variant information
Variant position:
7
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Proline (P) to Serine (S) at position 7 (P7S, p.Pro7Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and hydrophobic (P) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In HMND3; induces hyperphosphorylation of neurofilaments; no effect on cytoplasmic location; no effect on dimerization.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
7
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
205
The length of the canonical sequence.
Location on the sequence:
MTERRV
P FSLLRGPSWDPFRDWYPHSR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MTERRVP FSLLRGPSWDPFRDWYP-HSR
MTERRVP FSLLRSPSWDPFRDWYPAHS
Mouse MTERRVP FSLLRSPSWEPFRDWYPAHS
Rat MTERRVP FSLLRSPSWEPFRDWYPAHS
Pig MTERRVP FSLLRSPSWDPFRDWYPAHS
Bovine MAERRVP FSLLRGPSWDPFRDWYPAHS
Chicken MAERRVP FTFLTSPSWEPFRDWYH-GS
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 205
Heat shock protein beta-1
Modified residue
12 – 12
Omega-N-methylarginine
Modified residue
15 – 15
Phosphoserine; by MAPKAPK2 and MAPKAPK3
Modified residue
26 – 26
Phosphoserine
Mutagenesis
15 – 15
S -> D. Mimicks phosphorylation state, leading to dreased ability to act as molecular chaperones; when associated with D-78 and D-82.
Literature citations
Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II.
Landry J.; Lambert H.; Zhou M.; Lavoie J.N.; Hickey E.; Weber L.A.; Anderson C.W.;
J. Biol. Chem. 267:794-803(1992)
Cited for: PROTEIN SEQUENCE OF 76-89; PHOSPHORYLATION AT SER-78 AND SER-82;
Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins.
Stokoe D.; Engel K.; Campbell D.G.; Cohen P.; Gaestel M.;
FEBS Lett. 313:307-313(1992)
Cited for: PHOSPHORYLATION AT SER-15; SER-78 AND SER-82 BY MAPKAPK2;
A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress.
Clifton A.D.; Young P.R.; Cohen P.;
FEBS Lett. 392:209-214(1996)
Cited for: PHOSPHORYLATION AT SER-15; SER-78 AND SER-82;
Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation.
Rogalla T.; Ehrnsperger M.; Preville X.; Kotlyarov A.; Lutsch G.; Ducasse C.; Paul C.; Wieske M.; Arrigo A.P.; Buchner J.; Gaestel M.;
J. Biol. Chem. 274:18947-18956(1999)
Cited for: FUNCTION; SUBUNIT; PHOSPHORYLATION AT SER-15; SER-78 AND SER-82; MUTAGENESIS OF SER-15; SER-78 AND SER-82;
Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation.
De Souza A.I.; Wait R.; Mitchell A.G.; Banner N.R.; Dunn M.J.; Rose M.L.;
Circ. Res. 97:192-198(2005)
Cited for: PHOSPHORYLATION AT SER-78 AND SER-82; IDENTIFICATION BY MASS SPECTROMETRY;
PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the MAPKAP kinase MK5.
Kostenko S.; Johannessen M.; Moens U.;
Cell. Signal. 21:712-718(2009)
Cited for: FUNCTION; PHOSPHORYLATION AT SER-78 AND SER-82;
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
Olsen J.V.; Vermeulen M.; Santamaria A.; Kumar C.; Miller M.L.; Jensen L.J.; Gnad F.; Cox J.; Jensen T.S.; Nigg E.A.; Brunak S.; Mann M.;
Sci. Signal. 3:RA3-RA3(2010)
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-65; SER-78; SER-82 AND SER-199; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
Toward a comprehensive characterization of a human cancer cell phosphoproteome.
Zhou H.; Di Palma S.; Preisinger C.; Peng M.; Polat A.N.; Heck A.J.; Mohammed S.;
J. Proteome Res. 12:260-271(2013)
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-78; SER-82; SER-86; THR-174; SER-176 AND SER-199; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
Bian Y.; Song C.; Cheng K.; Dong M.; Wang F.; Huang J.; Sun D.; Wang L.; Ye M.; Zou H.;
J. Proteomics 96:253-262(2014)
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-78; SER-82; SER-86; SER-98 AND SER-199; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
Axonal Neuropathies due to Mutations in Small Heat Shock Proteins: Clinical, Genetic, and Functional Insights into Novel Mutations.
Echaniz-Laguna A.; Geuens T.; Petiot P.; Pereon Y.; Adriaenssens E.; Haidar M.; Capponi S.; Maisonobe T.; Fournier E.; Dubourg O.; Degos B.; Salachas F.; Lenglet T.; Eymard B.; Delmont E.; Pouget J.; Juntas Morales R.; Goizet C.; Latour P.; Timmerman V.; Stojkovic T.;
Hum. Mutat. 38:556-568(2017)
Cited for: VARIANTS HMND3 SER-7; LEU-39; ASP-53; TRP-127; ARG-128; ILE-151; 175-GLN--LYS-205 DEL; ILE-180 AND LEU-187; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS HMND3 SER-7; ASP-53; ARG-128 AND LEU-187;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.